W. Sause
15 works · 1,521 citations · h-index 4
Top works
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
- O-035 Phase III trial of concurrent chemotherapy and radiotherapy(CT/RT) vs CT/RT followed by surgical resection for stage IIIa(pN2)non-small cell lung cancer (NSCLC): Outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309)
- Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer
- Radiotherapy of bronchogenic carcinoma. Analysis of a treatment schedule designed for use with hyperbaric oxygen.
- 126 Factors which influence quality of life in patients with non-small cell lung cancer (NSCLC): A radiation therapy oncology group study (RTOG 89-01)
- PD-121 Increasing tumor volume is predictive of poor overall- andprogression free survival: Secondary analysis of the Radiation Therapy Oncology Group (RTOG) 93-11 Phase I–II radiation dose escalation study in patients with inoperable non-small cell lung cancer (NSCLC)
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Lung Cancer Committee.
- Predictors of Lung Toxicity from the RTOG 9311 Radiation Dose Escalation Trial: GTV Position is Important
- 238 Response, failure patterns and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC)
- Improved cancer outcomes across multiple institutions using an integrated data system
- 244 Toxicity in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy (CT) radiation therapy (RT) for locally advanced non-small cell carcinoma of the lung (NSCLC)
- Are patients with supraclavicular node metastases in non-small cell lung cancer (NSCLC) curable with chemoradiotherapy?
- Clinical experiences in multi-institutional trials-RTOG
- PD-074 Does response rate in the induction chemotherapy predictsurvival for locally advanced non-small cell lung cancer (LANSCLC)?: Secondary analysis of RTOG 8804/8808
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial